Screener
McKesson MCK Oncology & Multispecialty — Other adjustments
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by McKesson in its filing.
Tagged under the XBRL concept us-gaap:GoodwillPurchaseAccountingAdjustments.
The source filing: McKesson’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 5:29 PM EDT
- Fiscal quarter
- Q1 FY2027
- Calendar quarter
- Q2 2026
- Accession
- 0000927653-26-000234
| (In millions) | North American Pharmaceutical | Oncology & Multispecialty | Prescription Technology Solutions | Medical-Surgical Solutions | Total |
|---|---|---|---|---|---|
| Balance, March 31, 2026 | $2,781 | $3,963 | $2,065 | $2,507 | $11,316 |
| Goodwill acquired | — | 13 | — | — | 13 |
| Disposals | — | (2) | — | — | (2) |
| Foreign currency translation adjustments, net | (26) | — | — | — | (26) |
| Other adjustments (1) | — | (23) | — | — | (23) |
| Balance, June 30, 2026 | $2,755 | $3,951 | $2,065 | $2,507 | $11,278 |
Item 1. Condensed Consolidated Financial Statements.
FAQ
- What is McKesson's oncology & multispecialty — other adjustments?
- McKesson (MCK) reported oncology & multispecialty — other adjustments of -$23M in Q2 2026.
- What does oncology & multispecialty — other adjustments mean?
- Miscellaneous adjustments to segment financial results that do not fall into standard categories like restructuring or impairment. These often include one-time accounting corrections, measurement period adjustments, or non-recurring operational items.
Ask your AI about McKesson's oncology & multispecialty — other adjustments.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude